Items where authors include "Lespessailles, E"
Conference or Workshop Item
Helliwell, P, Lespessailles, E, Shuler, CL et al. (4 more authors) (2018) Ixekizumab Provides Sustained Improvement In Signs And Symptoms In Patients With Active Psoriatic Arthritis: Two Year Results From A Phase 3 Trial. In: 20th PANLAR Meeting, 07-10 Apr 2018, Buenos Aires, Argentina.
Proceedings Paper
Helliwell, P, Lespessailles, E, Shuler, C et al. (4 more authors) (2018) Ixekizumab Provides Sustained Improvement in Signs and Symptoms in Patients with Active Psoriatic Arthritis: Two-Year Results from a Phase 3 Trial. In: Journal of Rheumatology. 73rd Annual Meeting of The Canadian-Rheumatology-Association (CRA), 21-24 Feb 2018, Vancouver, Canada. Journal of Rheumatology Publishing Co., Ltd. , pp. 998-999.
Chandran, V, Fleischmann, R, Lespessailles, E et al. (4 more authors) (2018) Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: three year results from a phase 3 study (SPIRIT-P1). In: Acta Dermato-Venereologica. 5th World Psoriasis & Psoriatic Arthritis Conference, 27-30 Jun 2018, Stockholm, Sweden. Society for Publication of Acta Dermato-Venereologica , pp. 23-24.